- Cefditoren sodium
-
- $0.00 / 5mg
-
2025-07-09
- CAS:104146-53-4
- Min. Order: 5mg
- Purity: 95%+
- Supply Ability: 1000mg
- Cefditoren sodium
-
- $46.00 / 2mg
-
2024-10-24
- CAS:104146-53-4
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| sodium (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-[(E)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Basic information |
Product Name: | sodium (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-[(E)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | Synonyms: | (6R,7R)-7-[(Z)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetylamino]-3-[(Z)-2-(4-methyl-5-thiazolyl)vinyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]octa-2-ene-2-carboxylic acid sodium salt;3-[(Z)-2-(4-Methylthiazol-5-yl)vinyl]-7β-[[(Z)-(2-aminothiazol-4-yl)(methoxyimino)acetyl]amino]cepham-3-ene-4-carboxylic acid sodium salt;ME-1206;(6R-(3(Z),6alpha,7beta(Z)))-7-(((2-Amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(2-(4-methyl-5-thiazolyl)ethenyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid monosodium salt;Cefditoren acid sodium salt;Cefditoren sodium;sodium (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-[(E)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;sodium (6R,7R)-7-((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-((Z)-2-(4-methylthiazol-5-yl)vinyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | CAS: | 104146-53-4 | MF: | C19H19N6NaO5S3 | MW: | 530.57 | EINECS: | | Product Categories: | Chiral Reagents;Heterocycles;Intermediates & Fine Chemicals;Metabolites & Impurities;Pharmaceuticals;Sulfur & Selenium Compounds | Mol File: | 104146-53-4.mol | ![sodium (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-[(E)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Structure](CAS/GIF/104146-53-4.gif) |
| sodium (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-[(E)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical Properties |
storage temp. | 4°C, away from moisture | solubility | DMSO : 31.25 mg/mL (59.12 mM; ultrasonic and warming and heat to 60°C) | form | Solid | color | White to light yellow | Water Solubility | H2O: 2mg/mL, clear (Warmed) |
| sodium (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-[(E)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Usage And Synthesis |
Uses | Third generation cephalosporin; active metabolite of orally absorbed pivaloyloxymethyl ester prodrug. An antibacterial. | Biological Activity | Cefditoren sodium is orally available, broad spectrum third-generation cephalosporin antibiotic. Cefditoren sodium is active against both gram-negative and gram-positive bacteria. It is commonly used for treatment of chronic bronchitis, community-acquired pneumonia, pharyngitis/tonsillitis, and uncomplicated skin and skin-structure infections. | in vivo | Pharmacokinetics in mice[1]:
Cefditoren (mg/kg) | C0 (μg/ml) | t1/2 (h) | AUClast (μg× h/ml) | Tlast (h) | 6.25 | 53.0 | 0.9 | 30.4 | 6 | 12.5 | 168.4 | 1.1 | 64.1 | 8 | 25 | 232.5 | 0.9 | 101.3 | 8 | 50 | 290.6 | 1.1 | 124.4 | 8 |
|
| sodium (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-[(E)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Preparation Products And Raw materials |
|